A Dallas biotech investment firm raised more than $2.1 million as part of a round of funding it participated in for a cancer drug maker in Belgium, a filing shows.
A Dallas biotech investment firm raised more than $2.1 million as part of a round of funding it participated in for a cancer drug maker in Belgium, a filing shows.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.